ID   LPB1
AC   CVCL_ZX91
SY   LiPSC_LPB1; LCL(PB)-derived iPSC, clone #1
DR   GEO; GSM2185124
DR   Wikidata; Q102114474
RX   PubMed=27716287;
CC   Sequence variation: Mutation; HGNC; HGNC:8607; PRKN; Unexplicit; Ex6-7del; Zygosity=Homozygous (from parent cell line).
CC   Transformant: NCBI_TaxID; 10376; Epstein-Barr virus (EBV).
CC   Omics: Transcriptomics; Microarray.
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C198603; Parkinson disease 2, autosomal recessive juvenile
DI   ORDO; Orphanet_2828; Young-onset Parkinson disease
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_ZX88 ! PB(LCL)
SX   Male
AG   50Y
CA   Induced pluripotent stem cell
DT   Created: 29-10-20; Last updated: 10-04-25; Version: 7
//
RX   PubMed=27716287; DOI=10.1186/s13041-016-0267-6; PMCID=PMC5046991;
RA   Fujimori K., Tezuka T., Ishiura H., Mitsui J., Doi K., Yoshimura J.,
RA   Tada H., Matsumoto T., Isoda M., Hashimoto R., Hattori N.,
RA   Takahashi T., Morishita S., Tsuji S., Akamatsu W., Okano H.;
RT   "Modeling neurological diseases with induced pluripotent cells
RT   reprogrammed from immortalized lymphoblastoid cell lines.";
RL   Mol. Brain 9:88.1-88.14(2016).
//